Please login to the form below

Not currently logged in
Email:
Password:

masitinib

This page shows the latest masitinib news and features for those working in and with pharma, biotech and healthcare.

FDA clears new ALS drug Radicava ahead of schedule

FDA clears new ALS drug Radicava ahead of schedule

In March, French biotech AB Science said a pivotal trial of its lead drug masitinib for ALS hit its objectives of reducing declines in functioning when added to Riluzole therapy.

Latest news

More from news
Approximately 3 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics